カワニシホールディングス 2017年6月期第2四半期報告書
https://www.olba.co.jp/ir/upload_file/m004-m004_01/20170303report.pdfThe evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.
カワニシホールディングス 2017年6月期第2四半期報告書
This document summarizes the financial report for the second quarter of the fiscal year ending June 2017 for Kawanishi Holdings. The consolidated sales reached 53.184 billion yen, with operating profit at 571 million yen, ordinary profit at 590 million yen, and net profit at 377 million yen. Notably, sales of equipment in the Tohoku region increased significantly by 125% compared to the previous year. The medical equipment business accounts for over 90% of total sales. The company is also launching a new business for breath-based breast cancer screening and promoting collaboration in the medical field. The nursing care product business continues to grow, with plans to expand its operational base. Overall, there is a notable increase in sales and profits, indicating a positive growth strategy for the future.